81
52
Growth Score 81 in past quarter
-7 pts
Heat Score 52 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1552842
CellenGene is a biopharmaceutical company that develops next-generation CAR-T therapies targeting refractory solid tumors.
About the Company
CellenGene is a biopharmaceutical company that specialises in the development of next-generation CAR-T therapies targeting refractory solid tumors. Utilizing immune cells derived from healthy donors, the company aims to create "off-the-shelf" treatments for cancers such as pancreatic, ovarian, and mesothelioma.